Biosuccess Biotech Co. Ltd. ,
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase 1
Terminated
- Conditions
- Acute Myelogenous LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Biosuccess Biotech Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT01795924
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸University of Kentucky Medical Center, Lexington, Kentucky, United States
News
No news found